AHRI’s clinical trial researchers, who are part of the wider STREAM Trial – a multi-country clinical trial that seeks to examine shortened regimens for multidrug-resistant tuberculosis (MDR-TB), successfully publish the STREAM Stage 2 Trial findings on THE LANCET.
